Search
Now showing items 1-10 of 21
Positron emission tomography with fluorine-deoxyglucose in sarcomas and non-sarcoma non-epithelial tumors Utilidad del estudio PET con FDG en la evaluación de sarcomas de diverso origen y de tumores no sarcoma-no epiteliales
(2012)
Background: The usefulness of positron emission tomography (PET) with fluorine-deoxyglucose (FDG) in sarcomas and non-sarcoma non-epithelial (NSNE) tumors is not clearly defined. Aim: To report a Chilean experience with ...
The role of imaging in the management of patients with nonmelanoma skin cancer: Diagnostic modalities and applications
(Mosby Inc., 2017)
© 2015 American Academy of Dermatology, Inc. While uncomplicated cases of nonmelanoma skin cancer can be treated with surgery, destruction, or topical therapy alone, advanced or neglected cases require more complex management ...
Frecuencia de malignidad en incidentalomas tiroideos detectados con tomografía por emisión de positrones/tomografía computada (PET/CT) con F18-FDG de cuerpo entero
(Sociedad Médica Santiago, 2020)
Background: Thyroid incidentalomas detected by F-18-Fludeoxyglucose (FDG) PET/CT are defined as an incidental and unexpected thyroid focus present in a patient studied for a non-thyroid disease. Aim: To assess the frequency ...
Prognostic value of PET/CT in lung cancer. Retrospective analysis of 47 patients Valor pronóstico del PET/CT en cáncer pulmonar. Estudio de sobrevida y caracterización metabólica tumoral
(2013)
Background: PET/CT (Positron emission tomography/computed tomography) is a hybrid image modality widely used in oncology, for staging, therapy evaluation or follow up. Aim: To evaluate the prognostic value of PET/CT in ...
Utilidad pronóstica del PET/CT en cáncer de páncreas
(Sociedad Médica de Santiago, 2018-04)
Background: Pancreatic cancer is the tenth most prevalent cancer in world, and represents the fourth cause of cancer death. It has a five year-survival of 5%. Aim: To assess the prognostic value of PET/CT in pancreatic ...
Prognostic value of PET/CT in pancreatic cancer Utilidad pronóstica del PET/CT en cáncer de páncreas
(Sociedad Medica de Santiago, 2018)
© 2018, Sociedad Medica de Santiago. All rights reserved. Background: Pancreatic cancer is the tenth most prevalent cancer in world, and represents the fourth cause of cancer death. It has a five year-survival of 5%. Aim: ...
Chilean experience with the use of F-18-deoxyglucose positron emission tomography
(2007)
Background: Clinical oncology is the main application of F-18- deoxyglucose (FDG) positron emission tomography (PET). Aim: To evaluate the first 1, 000 patients studied with FDG PET in Chile. Material and methods: Retrospective ...
Simulation of hypoxia PET-tracer uptake in tumours: Dependence of clinical uptake-values on transport parameters and arterial input function
(Elsevier, 2020)
Poor radiotherapy outcome is in many cases related to hypoxia, due to the increased radioresistance of hypoxic tumour cells. Positron emission tomography may be used to non-invasively assess the oxygenation status of the ...
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma
(Elsevier Inc., 2017)
© 2016 Elsevier Inc. Purpose To assess the predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) for disease recurrence after immunochemotherapy (R-CHT) and mediastinal ...
Multiple primary malignant neoplasms detected by PET/CT in cancer patients Cáncer sincrónico y metacrónico detectado con PET/CT en población oncológica
(Sociedad Medica de Santiago, 2017)
© 2018, Sociedad Medica de Santiago. All rights reserved. Background: Imaging with F18-fluorodeoxyglucose PET/CT is used to determine sites of abnormal glucose metabolism and can be used to characterize and localize many ...